MedTrace Logo

Neurocognitive Follow-Up (FU) Study

NCT04962035 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2023-03-24

No results posted yet for this study

Summary

This is a follow-up study of a recently completed trial (17.14.INF) evaluating the growth of pre-term infants. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA).

Conditions

  • Cognitive Developmental Delay

Interventions

OTHER

Neurocognitive Follow-up

Standard clinical and parent-reported outcomes on cognitive development, temperament and overall health conditions.

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Eligibility

Min Age
17 Months
Max Age
25 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-26
Primary Completion
2021-11-30
Completion
2021-12-22

Countries

  • Poland
  • Slovakia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962035 on ClinicalTrials.gov